BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//N2 Canada - ECPv6.17.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:N2 Canada
X-ORIGINAL-URL:https://n2canada.ca
X-WR-CALDESC:Events for N2 Canada
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20250123T110000
DTEND;TZID=America/Toronto:20250123T120000
DTSTAMP:20250110T200730Z
CREATED:20241223T185604Z
LAST-MODIFIED:20250110T200730Z
UID:14152-1737630000-1737633600@n2canada.ca
SUMMARY:Securing Funding for Clinical Trials
DESCRIPTION:Webinar objectives: \n\n\nIdentify various funding strategies for pediatric and perinatal clinical trials in Canada\, including academic grants and industry partnerships. \n\n\nDevelop realistic expectations regarding the timeline and effort required to fund clinical trials through shared examples. \n\n\nUnderstand different strategies when approaching industry and academic funders and identify key factors for successful proposals. \n\n\nMeet the speakers! \nEbele Ola VP\, Medical Affairs\, Janssen Canada\nDr. Ebele Ola is the Vice-President of Medical Affairs at Janssen Canada. She leads a team of Medical Affairs Professionals dedicated to the generation\, analysis\, and unbiased dissemination of scientific data to health care professionals\, to support improved patient outcomes. She is a member of the Janssen Canada Leadership Team. \nEbele has been with Janssen in Canada since 2008. Prior to joining Johnson & Johnson\, Ebele was Medical Director and Principal Investigator\, overseeing a team of over 100 clinical research professionals in the conduct of Phase I to Phase III Clinical trials. During this period\, the company grew by 50 percent and inpatient capacity increased four-fold. \nIn 2016\, Ebele was recognized as a Healthcare Businesswomen’s Association Rising Star. She is passionate about Diversity\, Equity\, & Inclusion\, and she is the Executive Sponsor for the Janssen Women’s Leadership & Inclusion. \nEbele obtained her Medical Degree from the University of Toronto in Canada\, followed by a residency in Family Medicine at Mount Sinai Hospital in Toronto and a Sports Medicine Fellowship. Outside of her professional life\, she enjoys salsa dancing and traveling to new destinations with her husband and daughter. \nSrinivas Murthy\nClinical Associate Professor\, Department of Pediatrics\, Faculty of Medicine\, University of British Columbia \nThierry Lacaze-Masmonteil\nScientific Director\, Maternal Infant Child and Youth Research Network (MICYRN)
URL:https://n2canada.ca/event/secure-funding-for-clinical-trials/
LOCATION:Zoom
CATEGORIES:Collaborator Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/12/Unknown.png
END:VEVENT
END:VCALENDAR